C

Carasent ASA
OSE:CARA

Watchlist Manager
Carasent ASA
OSE:CARA
Watchlist
Price: 21.1 NOK Market Closed
Market Cap: 1.5B NOK
Have any thoughts about
Carasent ASA?
Write Note

Carasent ASA
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Carasent ASA
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
C
Carasent ASA
OSE:CARA
Total Current Liabilities
kr111.4m
CAGR 3-Years
20%
CAGR 5-Years
46%
CAGR 10-Years
4%
N
Nordhealth AS
OSE:NORDH
Total Current Liabilities
€9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Omda AS
OSE:OMDA
Total Current Liabilities
kr167.7m
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Carasent ASA
Glance View

Market Cap
1.5B NOK
Industry
Health Care

Carasent ASA is an investment management company, which in the development of entrepreneurial and e-health solutions. The company is headquartered in Oslo, Oslo. The company went IPO on 2002-04-08. The company operates through its subsidiary Evimeria EMR AB, which offers digital eHealth services primarily at specialist care, primary care and paramedics. The firm provides Webdoc, a Web-based care management system for health professionals that reduces the risk of resource-intensive routines. The system is customizable and also offers integration solutions. The firm is active in the Nordic region.

CARA Intrinsic Value
23.26 NOK
Undervaluation 9%
Intrinsic Value
Price
C

See Also

What is Carasent ASA's Total Current Liabilities?
Total Current Liabilities
111.4m NOK

Based on the financial report for Jun 30, 2024, Carasent ASA's Total Current Liabilities amounts to 111.4m NOK.

What is Carasent ASA's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
4%

Over the last year, the Total Current Liabilities growth was 13%. The average annual Total Current Liabilities growth rates for Carasent ASA have been 20% over the past three years , 46% over the past five years , and 4% over the past ten years .

Back to Top